Jove
Visualize
Contact Us

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

269
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
269

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Female sex is associated with improved outcomes after surgery for pancreatic neuroendocrine neoplasms.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026
Same author

Long-term quality of life after surgery for intraductal papillary mucinous neoplasms in young patients.

Surgery·2026
Same author

Impact of sarcopenia and myosteatosis on early and long-term survival after surgical resection of pancreatic ductal adenocarcinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2026
Same author

Optimal Time Between Completion of Preoperative Chemotherapy and Surgery for Locally Advanced Pancreatic Cancer.

Annals of surgical oncology·2026
Same author

Postpancreatectomy Hemorrhage: Risk Factors and Outcomes.

Annals of surgery·2026
Same author

Neoadjuvant therapy for left-sided resectable pancreatic ductal adenocarcinoma: evidence-based shift or premature extrapolation?

Hepatobiliary surgery and nutrition·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 4, 2026

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

4.4K

Conversion Surgery for Advanced Pancreatic Cancer.

Thomas Hank1, Oliver Strobel1

  • 1Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.

Journal of Clinical Medicine
|November 14, 2019
PubMed
Summary

Neoadjuvant therapy (NAT) followed by conversion surgery is a growing strategy for locally advanced pancreatic cancer (LAPC). FOLFIRINOX shows promise, but outcomes vary, necessitating standardized prospective studies.

Keywords:
FOLFIRINOXconversion surgerylocally advanced pancreatic cancerneoadjuvant therapypancreatic cancer

More Related Videos

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

7.0K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

668

Related Experiment Videos

Last Updated: Jan 4, 2026

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer
12:07

Laparoscopic Radical Antegrade Modular Pancreatosplenectomy via Dorsal-Caudal Artery Approach for Pancreatic Neck-Body Cancer

Published on: November 18, 2022

4.4K
Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique
13:56

Robot Assisted Distal Pancreatectomy with Celiac Axis Resection DP-CAR for Pancreatic Cancer: Surgical Planning and Technique

Published on: August 14, 2021

7.0K
Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors
02:20

Application of Mid-Pancreatectomy with End-to-End Anastomosis in Pancreatic Benign Tumors

Published on: February 9, 2024

668

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Locally advanced pancreatic cancer (LAPC) was historically treated with palliative therapy.
  • The advent of effective chemotherapy regimens has led to increased use of neoadjuvant therapy (NAT) and conversion surgery for pancreatic ductal adenocarcinoma.
  • Evidence from prospective studies remains limited, with most data derived from retrospective analyses.

Purpose of the Study:

  • To review current neoadjuvant therapy (NAT) regimens for LAPC.
  • To analyze conversion rates, survival outcomes, and factors influencing post-resection results after NAT.
  • To discuss surgical strategies for conversion surgery in the context of LAPC.

Main Methods:

  • Review of recent large retrospective studies on NAT and conversion surgery for LAPC.
  • Analysis of different NAT regimens, focusing on FOLFIRINOX.
  • Evaluation of reported conversion rates, survival data, and surgical approaches.

Main Results:

  • FOLFIRINOX is the most common NAT regimen, associated with high conversion rates.
  • Reported conversion rates vary widely (less than 5% to over 50%) due to heterogeneity in study design and criteria.
  • Long-term outcomes are heterogeneous, influenced by varying resectability criteria and treatment strategies.

Conclusions:

  • Radiological criteria for resectability become less definitive after NAT; surgical exploration is recommended for patients without progressive disease.
  • Conversion surgery for LAPC after NAT requires a focus on radical resection around peripancreatic vessels and should be performed in expert centers.
  • Future research must be prospective, include intention-to-treat analyses, and establish stringent criteria for inclusion and resection to clarify outcomes.